DFTX 8-K: SEC filing
Filed with the SEC on · accession 0001193125-26-453595
DFTX filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +6.4% by the first close after the filing.
Summary of the filing
Definium Therapeutics, Inc. furnished a Form 8-K announcing its financial results for the fiscal quarter ended September 30, 2026, and provided details about a related conference call and recent corporate highlights.
Key details
How DFTX stock reacted
Close before
$33.27
Nov 6, 2026
First close after
+6.37%
$35.39
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DFTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DFTX?
Click hereFrequently asked questions
What did DFTX file with the SEC on Nov 9, 2026?
DFTX filed a 8-K (SEC filing). Definium Therapeutics, Inc. furnished a Form 8-K announcing its financial results for the fiscal quarter ended September 30, 2026, and provided details about a related conference call and recent corporate highlights.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did DFTX stock react to this filing?
DFTX closed at $33.27 before the filing and $35.39 on Nov 9, 2026 (+6.37%).
Other DFTX SEC filings
- 10-Q · SEC filingNov 9, 2026
- SCHEDULE 13G · SEC filingNov 5, 2026
- 8-K · SEC filingSep 14, 2026
- 8-K · Fda approvalSep 8, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 12, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingJun 24, 2026
Get alerts when DFTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days